SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Beam Therapeutics Inc. (BEAM) (CIK 0001745999) (BEAM) — Sep 28, 2020

Beam Therapeutics Inc. (BEAM) (CIK 0001745999)
Date: Sept. 28, 2020 · CIK: 0001745999 · Accession: 0001193125-20-256653

AI Filing Summary & Sentiment

File numbers found in text: 333-249093

Date
September 28, 2020
Author
Not clearly detected
Form
CORRESP
Company
Beam Therapeutics Inc. (BEAM) (CIK 0001745999)

Letter

BEAM THERAPEUTICS INC.

26 Landsdowne Street

Cambridge, MA

September 28, 2020

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Beam Therapeutics Inc.

Registration Statement on Form S-1 (File No. 333-249093)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Beam Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on September 30, 2020, or as soon as possible thereafter. The Company hereby authorizes Marc Rubenstein or Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.

[Signature page follows]

Very truly yours,
BEAM THERAPEUTICS INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 BEAM THERAPEUTICS INC.

26 Landsdowne Street

 Cambridge, MA
02139

 September 28, 2020

 VIA EDGAR

 Securities and Exchange Commission

 Division of
Corporate Finance

 100 F Street, N.E.

 Washington, D.C. 20549

Re:
 Beam Therapeutics Inc.

 Registration Statement on Form S-1 (File
No. 333-249093)

 Request for Acceleration

Ladies and Gentlemen:

 Pursuant to Rule 461
under the Securities Act of 1933, as amended, Beam Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be
declared effective at 4:00 p.m. Eastern Time on September 30, 2020, or as soon as possible thereafter. The Company hereby authorizes Marc Rubenstein or Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or
withdraw this request for acceleration.

 Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.

 [Signature page
follows]

Very truly yours,

BEAM THERAPEUTICS INC.

By:

 /s/ Terry-Ann Burrell

Name:

Terry-Ann Burrell

Title:

Chief Financial Officer

 Signature Page to Acceleration Request